News of Note—Dynavax and Hilleman Labs
admin 3rd October 2017 Uncategorised 0Here is some other vaccine news of note for this week. More: News of Note—Dynavax and Hilleman Labs Source: fierce
read more
Here is some other vaccine news of note for this week. More: News of Note—Dynavax and Hilleman Labs Source: fierce
read moreHoping to improve on the flu vaccine status quo, researchers in England are kicking off the world’s first large human trial of a “universal” influenza shot. More: Vaccitech 'universal' flu shot set for phase 2 study in U.K. Source: fierce
read moreThe world already has a super-successful pneumococcal conjugate vaccine in Pfizer’s Prevnar 13, but that isn’t stopping PnuVax from pushing ahead with its own program. As it works toward its goal of eventually licensing a vaccine and providing low-cost doses
read moreFrench police searched a plant today where Merck KGaA makes thyroid drug Levothyrox as consumer complaints have piled up over a formulation change the drugmaker made at the request of French regulators. More: French police visit Merck KGaA plant in
read moreFacing a barrage of negative pricing attention earlier this year, pharmaceutical trade group PhRMA overhauled its membership criteria in a move to bolster the research-based industry’s image. Now, Sen. Claire McCaskill is wondering whether Allergan’s recent tribal licensing agreement is
read moreShire alleges that Allergan is in effect blocking competition in Medicare drug plans More: Shire sues Allergan in dry eye disagreement Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals